home / stock / rgen / rgen articles


RGEN Articles, Repligen Corporation - From 04/17/24

Stock Information

Company Name: Repligen Corporation
Stock Symbol: RGEN
Market: NASDAQ
Website: repligen.com

Menu

RGEN RGEN Quote RGEN Short RGEN News RGEN Articles RGEN Message Board
Get RGEN Alerts

News, Short Squeeze, Breakout and More Instantly...

Repligen to Report First Quarter 2024 Financial Results | Benzinga

WALTHAM, Mass., April 17, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first qua...

Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday | Benzinga

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday. Shares of Aehr Test Systems (NASDAQ: AEHR) fell sharply duri...

Repligen Appoints Maggie A. Pax to Board of Directors | Benzinga

WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors ...

What's Going On With Life Science-Focused Repligen Stock Today? | Benzinga

Repligen Corporation (NASDAQ:RGEN) reported fourth-quarter 2023 adjusted EPS of $0.33, in line with the consensus estimate. The life scie...

Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but is...

Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday. Shares of Booz Allen Hamilton Holding Corporation (NYSE: BAH) ros...

Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

WALTHAM, Mass., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technolog...

Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements | Benzinga

WALTHAM, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that on December 6, 2023, it entered into p...

Repligen Corporation to Present at Upcoming Investor Conferences | Benzinga

WALTHAM, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technolog...

Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s sessio...

Previous 10 Next 10